Shabir Madhi, professor of vaccinology at Wits University and director of the SAMRC's vaccine and infectious diseases analytics unit, who is leading the SA study, said Wednesday was an exciting moment.
Madhi said the 2,000 participants would be divided into two groups. “The eight here today will form part of group 1, which is the smallest group. Others will also be added to this group. He said the participants had been randomly selected, with half to receive a placebo and the other half the vaccine. “Only the pharmacist and the administrator of the vaccine know who receives what and who is assigned to which group.”
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
First African Covid-19 vaccine trial kicks off on SA soilIn a major milestone for the country, the continent and the global fight against the pandemic the first participants from across Africa will be vaccinated this week in a SA trial as the world searches for a prevention against acquiring Covid-19.
Source: TimesLIVE - 🏆 28. / 59 Read more »